Melanoma Research

Skip Navigation LinksHome > Current Issue > Contributor Index

June 2016 - Volume 26 - Issue 3 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 2 Next
Author Name Article
Abbate, Kelly T.

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Alberts, David S.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Allez, Matthieu

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Alonso, Lorenzo

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Andrews, Stephanie

New-onset toxicity with programmed death-1 inhibitor rechallenge

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bagot, Martine

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ballesteros, Ana

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Barbai, Tamás

Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Baroudjian, Barouyr

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bartels, Hubert G.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bartels, Peter H.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Berrocal, Alfonso

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Bertheau, Philippe

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Block, Matthew S.

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boni, Andrea

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brinckerhoff, Constance E.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Callahan, Margaret K.

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carvajal, Richard D.

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cerezuela, Pablo

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Chami, Ichrak

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chandra, Abhinav B.

Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chapman, Paul B.

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chekir-Ghedira, Leila

Antitumoral, antioxidant, and antimelanogenesis potencies of Hawthorn, a potential natural agent in the treatment of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chiriboga, Luis

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cranmer, Lee D.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
da Silva, Vinicius D.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
de la Cruz, Gelo

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
de la Cruz-Merino, Luis

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
de Oliveira, Jefferson K.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
del Barrio, Patricia

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Díaz-Beveridge, Rodrigo

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Ding, Ya

Safety of immune checkpoint inhibitors in Chinese patients with melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Doma, Viktória

Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dronca, Roxana S.

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dummer, Reinhard

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Duquennoy-Martinot, Véronique

Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Eggermont, Alexander M.M.

Ultrasound of the sentinel node in melanoma patients: echo-free island is a discriminatory morphologic feature for node positivity

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ernstoff, Marc S.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Espinosa, Enrique

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Esplin, Brandt L.

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fadul, Camilo E.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fisher, Jan L.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Floudas, Charalampos S.

Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Friedman-Jiménez, George

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gabert, Pierre-Elliott

Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ghedira, Kamel

Antitumoral, antioxidant, and antimelanogenesis potencies of Hawthorn, a potential natural agent in the treatment of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Glazer, Evan S.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Glick, Michael

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Goldinger, Simone M.

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gornet, Jean-Marc

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Guerreschi, Pierre

Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Guillém, Vicente

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Guo, Yiqun

Safety of immune checkpoint inhibitors in Chinese patients with melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gupta, Arjun

Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Hampton, Thomas H.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hannallah, Franck

Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Hennebelle, Thierry

Antitumoral, antioxidant, and antimelanogenesis potencies of Hawthorn, a potential natural agent in the treatment of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Henning, Benjamin

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hill, Eboné

New-onset toxicity with programmed death-1 inhibitor rechallenge

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Howell, Brittny S.

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Imrédi, Eleonóra

Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Jamal, Sumayah

Endothelin-1 in the tumor microenvironment correlates with melanoma invasion

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Jiang, Huayong

Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kamarachev, Jivko

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kenessey, István

Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kha, Stephanie T.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kluza, Jerome

Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Koshy, Thomas

Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Kottschade, Lisa A.

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Krouse, Robert S.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lebbé, Céleste

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Li, Dandan

Safety of immune checkpoint inhibitors in Chinese patients with melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Li, Jingjing

Safety of immune checkpoint inhibitors in Chinese patients with melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lian, Fangru

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Liu, Chuan

Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
López Castro, Rafael

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
López López, Rafael

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
López-Vivanco, Guillermo

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Lourenco, Nelson

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ludlow, Steven P.

New-onset toxicity with programmed death-1 inhibitor rechallenge

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Maatouk, Mouna

Antitumoral, antioxidant, and antimelanogenesis potencies of Hawthorn, a potential natural agent in the treatment of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Maillet, Marianne

Anti-PD1-induced collagenous colitis in a melanoma patient

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Malvehy, Josep

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Marchetti, Philippe

Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Markovic, Svetomir N.

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Márquez-Rodas, Iván

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Martín-Algarra, Salvador

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Martínez de Prado, Purificación

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Open Access
Abstract
PDF
+ Favorites
Request Permissions